L
Lenora A. Pluchino
Researcher at National Comprehensive Cancer Network
Publications - 12
Citations - 1591
Lenora A. Pluchino is an academic researcher from National Comprehensive Cancer Network. The author has contributed to research in topics: Cancer & Internal medicine. The author has an hindex of 5, co-authored 6 publications receiving 627 citations. Previous affiliations of Lenora A. Pluchino include Washington University in St. Louis.
Papers
More filters
Journal ArticleDOI
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Jaffer A. Ajani,Thomas A. D'Amico,David J. Bentrem,Joseph Chao,Carlos U. Corvera,Prajnan Das,Crystal S. Denlinger,Peter C. Enzinger,Paul T. Fanta,Farhood Farjah,Hans Gerdes,Michael Gibson,Robert E. Glasgow,James A. Hayman,Steven N. Hochwald,Wayne L. Hofstetter,David H. Ilson,Dawn E. Jaroszewski,Kimberly L. Johung,Rajesh N. Keswani,Lawrence Kleinberg,Stephen Leong,Quan P. Ly,Kristina A. Matkowskyj,Michael McNamara,Mary F. Mulcahy,Ravi Kumar Paluri,Haeseong Park,Kyle A. Perry,Jose M. Pimiento,George A. Poultsides,Robert E. Roses,Vivian E. Strong,Georgia L. Wiesner,Christopher G. Willett,Cameron D. Wright,Nicole R. McMillian,Lenora A. Pluchino +37 more
TL;DR: This selection from the NCCN Guidelines for Esophageal and Esophagogastric Junction Cancers focuses on recommendations for the management of locally advanced and metastatic adenocarcinoma of the esophagus and EGJ.
Journal ArticleDOI
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Jaffer A. Ajani,Thomas A. D'Amico,David J. Bentrem,Joseph Chao,David Cooke,Carlos U. Corvera,Prajnan Das,Peter C. Enzinger,Thomas Enzler,Paul T. Fanta,Farhood Farjah,Hans Gerdes,C. Michael Gibson,Steven N. Hochwald,Wayne L. Hofstetter,David H. Ilson,Rajesh N. Keswani,Sunnie Kim,Lawrence Kleinberg,Samuel J. Klempner,Jill Lacy,Quan P. Ly,Kristina A. Matkowskyj,Michael McNamara,Mary F. Mulcahy,Darryl Alan Outlaw,Haeseong Park,Kyle A. Perry,Jose M. Pimiento,George A. Poultsides,Scott I. Reznik,Robert Ross,Vivian E. Strong,Stacey Su,Hanlin L. Wang,Georgia L. Wiesner,Christopher G. Willett,Danny Yakoub,Harry H. Yoon,Nicole R. McMillian,Lenora A. Pluchino +40 more
TL;DR: Palliative management, which may include systemic therapy, chemoradiation, and/or best supportive care, is recommended for all patients with unresectable or metastatic cancer.
Journal ArticleDOI
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Timothy D Gilligan,Daniel W. Lin,Rahul Aggarwal,David D. Chism,Nicholas G. Cost,Ithaar Derweesh,Hamid Emamekhoo,Darren R. Feldman,Daniel M. Geynisman,Steven L. Hancock,Chad A. LaGrange,Ellis G. Levine,Thomas A. Longo,William T. Lowrance,Bradley Alexander McGregor,Paul Monk,Joel Picus,Phillip M. Pierorazio,Soroush Rais-Bahrami,Philip J. Saylor,Kanishka Sircar,David Smith,Katherine S. Tzou,Daniel A. Vaena,David J. Vaughn,Kosj Yamoah,Jonathan Yamzon,Alyse Johnson-Chilla,Jennifer Keller,Lenora A. Pluchino +29 more
TL;DR: Recommendations for the management of adult patients with nonseminomatous GCTs, the most common solid tumor in men between the ages of 20 and 34 years, are focused on.
Journal ArticleDOI
Myeloid growth factors, version 2.2017
Jeffrey Crawford,Pamela S. Becker,James O. Armitage,Douglas W. Blayney,Julio C. Chavez,Peter T. Curtin,Shira Dinner,Thomas Fynan,Ivana Gojo,Elizabeth A. Griffiths,Shannon Hough,Dwight D. Kloth,David J. Kuter,Gary H. Lyman,Mary Mably,Sudipto Mukherjee,Shiven B. Patel,Lia Perez,Adam Poust,Raajit K. Rampal,Vivek Roy,Hope S. Rugo,Ayman Saad,Lee S. Schwartzberg,Sepideh Shayani,Mahsa Talbott,Saroj Vadhan-Raj,Sumithira Vasu,Martha Wadleigh,Peter Westervelt,Jennifer L. Burns,Lenora A. Pluchino +31 more
TL;DR: This selection from the NCCN Guidelines for MGFs focuses on the evaluation of regimen- and patient-specific risk factors for the development of febrile neutropenia (FN), the prophylactic use of M GFs for the prevention of chemotherapy-induced FN, and assessing the risks and benefits of MGF use in clinical practice.
Journal ArticleDOI
Hematopoietic growth factors, version 1.2020: Featured updates to the NCCN guidelines
Pamela S. Becker,Elizabeth A. Griffiths,Laura Alwan,Kimo Bachiashvili,Anna Brown,Rita Cool,Peter T. Curtin,Shira Dinner,Ivana Gojo,Ashley Hicks,Avyakta Kallam,Wajih Zaheer Kidwai,Dwight D. Kloth,Eric H. Kraut,Daniel J. Landsburg,Gary H. Lyman,Ryan Miller,Sudipto Mukherjee,Shiven B. Patel,Lia Perez,Adam Poust,Raajit K. Rampal,Rachel P. Rosovsky,Vivek Roy,Hope S. Rugo,Sepideh Shayani,Sumithira Vasu,Martha Wadleigh,Kelly Westbrook,Peter Westervelt,Jennifer L. Burns,Jennifer Keller,Lenora A. Pluchino +32 more
TL;DR: The NCCN Guidelines for Hematopoietic Growth Factors provide suggestions for appropriate evaluation, risk determination, prophylaxis, and management of febrile neutropenia (FN).